LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders

Key Points • SARS-CoV-2 infection was associated with prolonged viral shedding, causing therapy delays and permanent discontinuations.• BsAb treatment was associated with negative antispike serostatus for at least 6 months… Click to show full abstract

Key Points • SARS-CoV-2 infection was associated with prolonged viral shedding, causing therapy delays and permanent discontinuations.• BsAb treatment was associated with negative antispike serostatus for at least 6 months after treatment completion.

Keywords: sars cov; impact sars; treatment; infection bispecific; cov infection

Journal Title: Blood Advances
Year Published: 2025

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.